19-11105242-C-CG
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000527.5(LDLR):c.337dupG(p.Glu113fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,198 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000014 ( 0 hom. )
Consequence
LDLR
NM_000527.5 frameshift
NM_000527.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.65
Genes affected
LDLR (HGNC:6547): (low density lipoprotein receptor) The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. The encoded protein is normally bound at the cell membrane, where it binds low density lipoprotein/cholesterol and is taken into the cell. Lysosomes release the cholesterol, which is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-11105242-C-CG is Pathogenic according to our data. Variant chr19-11105242-C-CG is described in ClinVar as [Pathogenic]. Clinvar id is 440560.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LDLR | NM_000527.5 | c.337dupG | p.Glu113fs | frameshift_variant | 4/18 | ENST00000558518.6 | NP_000518.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LDLR | ENST00000558518.6 | c.337dupG | p.Glu113fs | frameshift_variant | 4/18 | 1 | NM_000527.5 | ENSP00000454071.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250566Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135724
GnomAD3 exomes
AF:
AC:
1
AN:
250566
Hom.:
AF XY:
AC XY:
0
AN XY:
135724
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461198Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 726934
GnomAD4 exome
AF:
AC:
2
AN:
1461198
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
726934
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hypercholesterolemia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | UCSF Pediatric Lipid Clinic, University of California, San Francisco | Sep 25, 2019 | The p.E113fs variant segregates with elevated level of LDL-C in a family of 5 individuals. The allele frequency of this variant in the population is 0.00001 as reported by the ExAC database. - |
Hypercholesterolemia, familial, 1 Pathogenic:1
Pathogenic, no assertion criteria provided | research | Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, Academisch Medisch Centrum | - | - - |
not provided Pathogenic:1
Pathogenic, no assertion criteria provided | provider interpretation | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Jul 20, 2017 | p.Glu113Glyfs*17 (c.337dupG; also known as 338insG) in exon 4 of the LDLR gene (NM_000527.4) Given that this is a loss-of-function variant in a gene in which truncation is a known mechanism of disease, moderate case data and its rarity in the general population, we consider this variant disease-causing and we do feel it is suitable for assessing risk in healthy relatives ("predictive genetic testing"). This variant causes a shift in the reading frame of the LDLR gene, producing a truncated protein. Loss-of-function (truncated proteins) variants are a known mechanism of LDLR-associated familial hypercholesterolemia. The variant has been seen in at least 4 unrelated cases of familial hypercholesterolemia (not including this patient's family). There is moderate case data. This variant was present in 4 of 46 unrelated patients with familial hypercholesterolemia (Robles-Osorio et al, 2006), and was a "common" variant identified amongst 123 unrelated Mexican patients (per an abstract by Vazques Cardenas et al, 2015). This variant is not present in ClinVar; however another truncating variant at this codon (c.337G>T; p.Glu113Ter) is classified as pathogenic by four laboratories. The variant was reported online in 1 of 122,762 individuals in the Genome Aggregation Consortium Dataset (gnomAD; http://gnomad.broadinstitute.org/), which currently includes variant calls on >140,000 unrelated individuals of African, Asian, European, Ashkenazi, Latino descent. Specifically, the variant was observed in 1 of 16,789 individuals of Latino descent (MAF=0.003%). The phenotype of those individuals is not publicly available. The dataset is comprised of multiple cohorts, some of which were recruited from the general population, others were enriched for common cardiovascular disease. Note that other variants with strong evidence for pathogenicity have been seen at similar frequencies in datasets like this so this does not necessarily rule out pathogenicity (Pan et al 2012). - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 13, 2020 | The c.337dupG pathogenic mutation, located in coding exon 4 of the LDLR gene, results from a duplication of G at nucleotide position 337, causing a translational frameshift with a predicted alternate stop codon (p.E113Gfs*17). This alteration (referred to as 338insG) has been detected in a cohort of individuals reported to have familial hypercholesterolemia (Robles-Osorio L et al. Arch. Med. Res., 2006 Jan;37:102-8). This alteration was also detected in a Mexican family with familial hypercholesterolemia. In this family, two homozygous children were reported, and both had higher LDL-C and total cholesterol levels than their heterozygous parents and sibling (Wong KHY et al. Mol Genet Genomic Med, 2019 12;7:e1007). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
Familial hypercholesterolemia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 17, 2024 | This sequence change creates a premature translational stop signal (p.Glu113Glyfs*17) in the LDLR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LDLR are known to be pathogenic (PMID: 20809525, 28645073). This variant is present in population databases (rs752191968, gnomAD 0.003%). This premature translational stop signal has been observed in individuals with familial hypercholesterolemia (PMID: 16314194). This variant is also known as 338insG. ClinVar contains an entry for this variant (Variation ID: 440560). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at